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Background: Sepsis is a prevalent condition in critically ill patients and may be associated with thiamine deficiency
(TD). The aim of this study was to evaluate the effect of TD on inflammation, oxidative stress and cellular
recruitment in a sepsis model.
Methods: The experimental sepsis model, cecal ligation and puncture (CLP), was utilized on mice in comparison
with a sham procedure. The following four groups were compared against each other: SHAM with AIN93G
complete chow, SHAM with thiamine deficient (TD) chow, CLP with AIN93G complete chow, and CLP with TD
chow. Thiamine pyrophosphate (TPP) blood concentrations were determined, and blood and peritoneal fluid were
evaluated for differences in TNF-alpha, IL-1, IL-6, KC and MCP-1/CCL2 levels. In addition, the levels of 4-HNE adducts
in liver proteins were evaluated by Western Blot.
Results: The mean TPP blood concentration from the mice fed with the complete chow was 303.3 ± 42.6 nmol/L, and
TD occurred within 10 days. TNF-α and MCP-1 concentrations in the peritoneal fluid were significantly greater in the
CLP with TD chow group when compared with the other groups. The blood IL-1β level, however, was lower in the
CLP with TD chow group. Liver 4-HNE levels were highest in the TD chow groups. Blood mononuclear cell numbers, as
well as peritoneal total leukocyte, mononuclear cell and neutrophil numbers were greater in the CLP with TD chow
group. Peritoneal bacterial colony forming units (CFU) were significantly lower in the CLP with TD chow group.
Conclusion: TD was associated with greater bacterial clearance, oxidative stress and inflammatory response changes.
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Several clinical conditions, such as trauma, burn, severe
acute illness and major postoperative surgery generate a
series of organic response reactions in response to these
injuries, called the systemic inflammatory response syn-
drome (SIRS). When SIRS is associated with an infection,
it is defined as sepsis [1-3]. Epidemiological studies world-
wide [4-6] and in Brazil [7,8] indicate that sepsis is a* Correspondence: sergio.d.cunha@gmail.com
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distribution, and reproduction in any mediumprevalent condition with a high mortality rate that is associ-
ated with the emergence of multidrug-resistant pathogens
[9,10] while also generating high social and financial costs
[11]. Thiamine (vitamin B1) is a water soluble vitamin that
does not accumulate in the body; therefore, it has to be
ingested daily [12]. Thiamine pyrophosphate (TPP; the bio-
logically active form of vitamin B1) is an important mito-
chondrial enzyme cofactor [12] with a key role in energy
balance. In addition, TPP participates as a transketolase co-
factor in the pentose phosphate pathway, a pathway that re-
plenishes NADPH, which is necessary for the recovery of
the reduced form of glutathione (GSH) from its oxidized
form. TPP is also a cofactor of the α-ketoglutaratentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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the recovery of cellular reducing power [13].
The prevalence of TD in critically ill patients has been
described [14-16] and was associated with increased mor-
bidity and mortality [16]. Recent studies have demonstrated
that additional attention is needed in the identification of
thiamine deficiency (TD) and that thiamine supplementa-
tion is necessary not only in intensive care unit patients but
also in patients with heart failure [15,17,18].
Evidence that TD may cause heart failure has been
demonstrated [12,19,20], whereby an increase in oxida-
tive stress due to TD led to the apoptosis of cardiomyo-
cytes [21] and produced cardiac remodeling [20,22].
Structural remodeling and the destruction of cardio-
myocyte mitochondria were also observed with TD [20].
A similar finding was observed in a study with human
neuroblastoma cells cultured under TD conditions [23].
Several neurological disorders have been associated with
TD, including acute confusion and changes in eye move-
ment and gait (Wernicke’s encephalopathy). These fin-
dings may be associated with chronic memory impairment
(Korsakoff ’s syndrome) [12,24,25]. Thiamine deficiency
may also be associated with brain degenerative condi-
tions such as Parkinson’s disease and Alzheimer’s dis-
ease [24-27]. Thiamine deficiency is also associated with
lesions of the endoplasmic reticulum of neurons [28].
The influence of TPP in an experimental model of sepsis
in dogs has recently been performed [29], and the follow-
ing outcomes were analyzed: blood pH, oxygen consump-
tion, base excess, mean arterial pressure and the cardiac
index. The authors observed recovery of all of these pa-
rameters in the animals treated with TPP, suggesting the
involvement of thiamine as a possible protective agent
against the onset of sepsis.
Sepsis is associated with an intense inflammatory re-
sponse [30]. In response to an injury, the initial inflamma-
tory response is the activation of the innate immunity
pathways. The innate inflammatory response is a series of
“primitive” non-specific reactions that occur in the early
hours after the interaction with a pathogen and involve
acute phase proteins, the complement system, dendritic
cells, macrophages and natural killer cells (NK), with the
end result being inflammation [31-34]. When an activated
macrophage comes into contact with a pathogen, it begins
to produce TNF-α, which is responsible for an increase
in vascular permeability. In addition, pathogen stimula-
tion of macrophages leads to the production of IL-1β
and IL-6, which have decisive roles in the genesis of
fever by acting on the central hypothalamic temperature
control system [34]. The chemotactic factors KC and
MCP-1 are involved in the recruitment of neutrophils
and monocytes, respectively, and are involved in the
perpetuation of the cellular response to injury. In paral-
lel, IL-10 secretion is a self-regulatory mechanism of theinflammatory response, acting as an anti-inflammatory
cytokine [30,31].
The cellular injury observed in sepsis produces highly
reactive biochemical intermediates from nitrogen and
oxygen [35]. Following an injury, we now know that the
increased production of reactive oxygen species (ROS)
and the increased activity of clearance mechanisms do
not necessarily indicate cell damage [35,36]. ROS have
the ability to react with proteins, lipids, and genetic ma-
terial. The products of these reactions are known today
and include 4-hydroxy 2-nonenal (4-HNE), an aldehyde
that results from the lipid peroxidation of the cell mem-
brane [37]. 4-HNE plays a key role in cell signaling and
redox balance [38,39], but in high concentrations, it can
be harmful to cells [37-39].
Experimental sepsis models are necessary to evaluate
some aspects of this clinical condition, due to ethical
constraints [40-42]. Many methods are used to simulate
hemodynamic, immunological and clinical sepsis events, in-
cluding surgical manipulation of organs (such as ligation or
perforation of the bowel loops) [42] and injection of bac-
teria or their components (e.g., endotoxins, such as gram-
negative lipopolysaccharides) into the bloodstream [41], or-
gans and anatomical cavities. These methods are not free of
criticisms from both a methodological standpoint [43,44]
and from technical and ethical standpoints, with regard to
animal handling [45]. These experimental models, however,
represent important tools for sepsis investigation.
This study analyzed the possible effect of thiamine defi-
ciency on changes in sepsis markers of inflammation (cy-
tokines), the balance of the oxidation-reduction system
(based on the presence of a marker of lipid peroxidation),
and the leukocyte recruitment profile. The hypothesis in
question was that thiamine deficiency in experimental
sepsis conditions could result in a pro-inflammatory pro-
file, with greater oxidative stress and cellular migration.
Methods
This study was approved by the ethics committee for the
use of animals for research at the Roberto Alcântara
Gomes Biology Institute – UERJ (CEUA/036/2011).
Animals and chow
Sixty-five male C57bl6 mice (Cecal – FIOCRUZ, Rio de
Janeiro, RJ, Brazil), between 6 and 8 weeks old, were
maintained in groups of 5 per cage, with free access to
water and food. The mice were exposed to a 12-hour
light cycle (lights off until 6 a.m. and a controlled
temperature (24°C ± 2°C). Two types of chow were used
for the study (Pragsoluções Biociências, Jaú, SP, Brazil).
The first type of chow contained all of the components
of a normal AIN93G chow [46]. The second chow type
was similar to the AIN93G chow but without the addition
of thiamine. Before each experiment, all groups were fed
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thiamine intake. Throughout the study, the animal’s body
weight and chow intake were measured.
Determining the time required for TD
To determine the time required to produce a TD, mice
were divided into five groups (five animals per group). Ini-
tially, all groups were fed with the AIN93G chow for seven
days to standardize the thiamine intake. The control group
was sacrificed after seven days, and blood was collected for
determination of the circulating thiamine levels by High
Performance Liquid Chromatography (HPLC). The other
four groups were fed with the thiamine deficient AIN93G
chow for an additional 10, 15, 20 and 25 days before euthan-
asia, and blood samples were collected for HPLC analyses.
We determined the normal concentration of TPP in C57bl6
mice, which is information that was not found in prior stud-
ies. Thiamine deficiency was defined as a TPP blood concen-
tration lower than two standard deviations below the mean.
The experimental sepsis procedure
For the experimental sepsis model experiments, forty mice
were divided into 4 groups (10 animals per group), and the
duration of the each experiment was 15 days. The experi-
mental groups were as follows: 1) a control group fed with
the AIN93G complete chow that was subjected to laparot-
omy without cecal ligation and puncture - CLP (sham); 2)
a group fed with the AIN93G complete chow that was sub-
jected to laparotomy and CLP; 3) a group fed with the
thiamine deficient AIN93G chow that was subjected to
laparotomy without CLP; and 4) a group fed with the
thiamine deficient AIN93G chow and subjected to laparot-
omy and CLP. For all groups, euthanasia was performed
24 hours after surgery to collect liver and blood samples.
The animals were anesthetized by intraperitoneal in-
jection of ketamine (65 mg/kg) and xylazine (13 mg/kg)
(Vetbrands Brazil, Campinas, SP, Brazil). A cutaneous ab-
dominal incision was made longitudinally and medially,
approximately 2 centimeters in length, followed by open-
ing of the peritoneum and cecum identification. The
cecum was then ligated to form a closed intestinal loop
and was perforated two times by an 18 gauge needle. The
closed loop was gently compressed to expose the abdom-
inal cavity to feces, and then the intestinal loop was placed
back into the abdominal cavity. The peritoneum and skin
were then sutured closed. Sham-operated mice were sub-
jected to identical procedures, except the cecum ligation
and puncture steps were omitted. After surgery, a sterile
saline subcutaneous injection was given for fluid replace-
ment [42,47]. Euthanasia was performed by an injection of
double the amount of anesthetic that was calculated for
each animal during the CLP or sham surgeries. Following
euthanasia, a blood sample was collected and the abdo-
men was opened for liver removal.Blood sample preparation for HPLC
The blood samples were preserved by refrigeration and
processed on the same day of collection. Whole blood was
frozen three times in liquid nitrogen to complete hemolysis
and was then centrifuged at 14,000 rcf. Then, after thirty
minutes of rest, the liquid phase was collected and depro-
teinated by the addition of 40% trichloroacetic acid (TCA).
The TCA was then extracted with five volumes of water-
saturated ethylic ether. To form the thiamine thiochrome
derivatives, the lower watery fraction was collected and
derivatized by adding 50 μL of potassium ferricyanide
(30.4 mmol/L) and 50 μL of sodium hydroxide (0.8 mol/L)
for each 1,000 μL aliquot of blood. The final sample was
frozen at −70°C for later analysis by HPLC [20].
The determination of TPP by HPLC/fluorescence
After derivatization, 100 μL of the final sample was
injected into a Hypersil Gold Amino column (Thermo,
USA) (250 × 4.6 mm, 5 μm particle). The shimadzu
HPLC system (Shimadzu, Kyoto, Japan) consisted of a
LC-10 AD pump valve 535, and a fluorimetric RF-
detection method was utilized, based on the excitability
of the thiochrome to fluorescent light.
The mobile phase (isocratic), with 30% acetonitrile in a
potassium phosphate buffer (0.1 M, pH 7.5), was pumped
at a flow rate of 1.0 mL/min. The fluorimetric detection
occurred at 450 nm emission and 370 nm excitation wave-
lengths [20,48]. Standards equivalent to 4.6875, 9.375,
18.75, 37.5, 75, 150, 300 and 600 nmol/L were prepared
for the construction of calibration curves.
The assessment of 4-HNE in the liver by western blot
About 100 mg of hepatic tissue were homogenized in
500 μl of lysis buffer (50 mM HEPES, 1 mM MgCl2, 1%
Triton X-100, 0.1% SDS, 10 mM EDTA; pH 6.4), containing
protease inhibitor cocktail Sigma-Adrich Fine Chemicals
(1.04 mM AEBSF, 800 nM aprotinin, 20 μM leupeptin,
40 μM bestatin, 15 μM pepstatin A and 14 μM E-64) in ice.
Tissue homogenate was centrifuged at 10,000 rpm for
10 min. the pellet was discarded and the supernatants were
used for protein quantification by the Peterson’s method.
Whole protein extracts (about 80 μg) were subjected to
electrophoresis in a 15% SDS-polyacrylamide gel under
reducing conditions. Proteins were transferred (25 mM
Tris, 192 mM glicine, pH 8.3, 20% methanol) to a nitro-
cellulose membrane at 4°C for 2 h. Membranes were
blocked with Tris-buffered saline solution containing
0.1% Tween 20 (TBS-T) and 5% bovine serum albumin
(BSA). The membranes were then incubated overnight
with anti-4-HNE antibody (1:1000), diluted in blocking
solution, washed in TBS-T, and finally incubated for 1 h
with horseradish peroxidase-conjugated anti-mouse anti-
body (1:10.000). The bands were revealed by chemilumines-
cence using the ECL substrate. Blots were exposed to ECL
Figure 1 Evolution of food intake and body mass. (A) The food intake was similar between groups in 10 and 15 days. Each bar represents
five animals (* p < 0.05). (B) Body mass gain was similar between groups in 10 and 15 days, and increased in AIN93G group. Each bar represents
five animals (# P <0.05). Therefore, until the 15th day the animals had a similar nutritional profile. All data are shown as mean ± SEM.
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by densitometric analysis of the exposed films (Adobe
Photoshop 5 programme) and the Ponceau S stained
membranes were used as a load control [49].
Blood and peritoneal fluid cell counts
Blood and peritoneal fluid samples were stained with
Giemsa stain for total and differential leukocyte counts by
optical microscopy at 1,000x magnification in a Neubauer
chamber [47].
Blood and peritoneal fluid cytokine determination
Determination of the blood and peritoneal fluid TNF-α,
IL-1, MCP-1/CCL2, IL-6 and KC levels were performed
by ELISA (Duo Set Kit - R & D systems, USA). ELISA
plate reading was performed on an ELISA plate reader
at 450 nm. The data were analyzed using the Soft Max
Pro program, and cytokine concentrations were deter-
mined based on their respective standard curves [47].
Peritoneal fluid colony-forming unit counts
The peritoneal fluid sample colony-forming unit (CFU)
counts were obtained by diluting the peritoneal fluid
samples 1:50 in sterile PBS, and then the diluted samples
were seeded in Petri dishes with TSA growth medium.






Control (AIN93G) 303.3 ± 19.06 -
10 days of TD chow 11.93 ± 1.11 < 0.001
15 days of TD chow 5.01 ± 0.67 < 0.001
After 10 days of TD chow, the thiamine pyrophosphate whole blood mean
concentration was lower than two standard deviations below the mean, what
characterizes thiamine deficiency in these animals.which the number of CFUs was counted. The whole
procedure was performed under sterile conditions [47].
Statistics analyses
A two-way ANOVA with a Sidak post-test was used to
analyze the differences between the groups for the bio-
chemical, immunological and cellular assays, to perform
a multiple comparison analysis between the variables
and to evaluate the contribution of each variable. The
software used was the Windows version of Prism 6.00
(GraphPad Software, San Diego, CA, USA). The signifi-
cance level was set at 0.05 [50].
Results
The body weight evolution and chow intake
The AIN93G chow intake by the mice increased during the
experiments; however, the average TD chow intake was re-
duced significantly by the 20th and 25th days (Figure 1A).
The body mass gain of the animals fed with the AIN93G
complete chow increased during the first experiment. Body
weight loss occurred at the 20th and 25th days in the
animals fed with the TD chow (Figure 1B).
Determining the efficiency and time required for TD
Initially, the time required for TD was determined.
Using HPLC, the mean retention times were 3.4 minutesTable 2 Thiamine pyrophosphate whole blood mean




(1) sham + AIN93G 383.6 ± 15.39 -
(2) sham + TD chow 41.4 ± 10.73 < 0.001 (compared to group 1)
(3) CPL + AIN93G 376.9 ± 12.17 -
(4) CLP + TD chow 40 ± 6.87 < 0.001 (compared to group 3)
The groups that were fed with TD chow for 15 days showed significantly
lower blood TPP concentrations than groups that were fed with complete
chow, profile that was similar to that found in the first experiment.
Figure 2 Determination of 4-HNE binding protein in the liver. (A) Western blot detail for each group (the image was sliced). (B) Optical
density analysis for each group, showing a significant increase of 4-HNE in TD chow groups without significant difference between the sham and
CLP groups. All data (B) are shown as mean ± SEM.
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sphate, and 6.2 minutes for the TPP. The TPP detection
limit was 4.6875 nmol/L. The mean blood TPP concentra-
tion in the mice fed the AIN93G complete chow was
303.3 ± 42.6 nmol/L. Thiamine deficiency was observed at
10 days in the mice fed the TD chow, and the blood
concentration of TPP in this group at this time point was
12.5 ± 2.4 nmol/L (Table 1).
The TPP blood concentrations were also assessed in the
sepsis experiments for validation purposes. As shown inFigure 3 Total number of leukocytes, mononuclears and neutrophils
Mononuclear cell number in the peripheral blood (B) was greater in the
others cellular types were similar among groups (A - B). In the peritoneal fluid aTable 2, both the sham and CLP groups that were fed with
TD chow for 15 days showed significantly lower blood TPP
concentrations than the sham and CLP groups that were
fed with complete chow (Table 2).Effect of TD on 4-HNE-protein adduct formation
As shown in Figure 2, we observed an increased level of
4-HNE adducts in liver proteins of TD animals when
compared with the animals fed with the AIN93G completein peripheral blood (A,B,C) and peritoneal fluid (D,E,F).
CLP group which was fed with the TD chow (p < 0,05) but the
ll cellular types were greater in the CLP groups, independent of chow type.
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sham and CLP groups (Figure 2).
Blood and peritoneal fluid cell counts
The total number of leukocytes and neutrophils in the
peripheral blood was similar in all groups. However, the
mononuclear cell number in the peripheral blood was
greater in the CLP group that was fed with the TD chow
(Figure 3 ABC). In the peritoneal fluid, total leukocyte,
mononuclear cell and neutrophil counts were greater in the
CLP groups, independent of whether the mice were fed the
AIN93G complete or the TD chow (Figure 3 DEF).
Effect of TD on the blood and peritoneal fluid cytokine
levels during sepsis
As shown in Figure 4, 24 h after CLP, the levels of TNF-α,
KC, IL-1 β and IL-6 were significantly increased when
compared with the sham groups. There were no differences
in the TNF-α, KC and IL-6 blood concentrations when theFigure 4 Blood cytokines 24 h after CLP. There were no differences in t
IL-1beta blood concentrations (B) were greater in AIN93G groups (independe
higher in CLP groups (n = 10 per group). KC blood levels (D) were higher in CCLP withTD chow group was compared with the CLP with
AIN93G complete chow group (Figure 4). Interestingly, the
IL-1β blood concentration was greater in the groups that
were fed the AIN93G complete chow (independent of
sham or CLP surgeries) when compared with the TD chow
groups (p < 0.0001) (Figure 4).
In Figure 5, the local peritoneal production of the cyto-
kines was evaluated. The peritoneal concentrations of KC,
IL-1β and IL-6 were greater in the CLP groups, independ-
ent of whether the mice were fed the complete or TD chow
(Figure 5). Interestingly, the MCP-1 and TNF-α peritoneal
fluid concentrations were significantly greater in the CLP
groups than in the other groups. Both CLP and TD
contributed to the elevation of MCP-1 and TNF-α in the
peritoneal fluid (Figure 5).Peritoneal fluid colony forming unit counts
The CLP group with AIN93G complete chow displayed a
higher bacterial clearance capacity when compared with allhe TNF-α (A) blood concentrations in all groups (n = 10 per group).
nt if sham or CLP) (n = 10 per group). IL-6 blood levels (C) tended to be
LP groups (n = 5 per group). All data are shown as mean ± SEM.
Figure 5 Peritoneal cytokines 24 h after CLP. (E) TNF-α peritoneal concentrations were higher in septic animals that were fed with TD chow
compared with CLP + AIN93G group (n = 10 per group). IL-1beta (F) (n = 10 per group), IL-6 (G) (n = 10 per group) and KC (I) (n = 5 per group)
peritoneal concentrations were higher in CLP groups. MCP-1 (H) (n = 5 per group) peritoneal concentrations were higher in septic animals that
were fed with TD chow compared with all others groups. All data are shown as mean ± SEM.
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chow, where the bacterial clearance was equivalent to the
sham animal groups (Figure 6).Discussion
In this study, we found that mice fed the thiamine
deficient AIN93G chow had significantly reduced levels
of the biologically active form of thiamine in their
serum, providing an experimental condition to assess
the effect of thiamine deficiency during sepsis.First, the normal blood TPP concentration and the
number of days necessary for TD induction with TD
chow in the mice were determined. Of note, this
information had not yet been described in previous
research.
The chow intake and mass gain were progressive in
the AIN93G complete chow fed animals. In contrast, a
decrease in the chow intake and a loss of body weight
throughout the study were observed in the mice fed
the thiamine deficient chow. This was a profile similar
to what was previously described with Wistar rats [20].
Figure 6 Peritoneal fluid colony forming unit (CFU) counts. The septic group that was fed with TD chow showed a lower bacterial
concentration in peritoneal fluid, similar to non-septic groups (sham), but the CLP + AIN93G group showed a higher bacterial concentration in
peritoneal fluid, what suggests a higher bacterial clearance capacity of the TD chow group. All data are shown as mean ± SEM.
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chow for 10 days displayed a significant reduction of TPP
in the blood, the decision to carry out the sepsis experi-
ments after 15 days was made to leave no doubt that
thiamine deficiency induction had occurred. Because there
was no significant difference in the body mass gain and
chow intake between the groups on the 15th day, it was not
necessary to perform a paired feeding to avoid errors re-
lated to ingestion of different amounts of calories, proteins
and other nutrients among the groups.
The levels of IL-6, MCP-1 and KC in the blood and of
IL-1β, IL-6 and KC in the peritoneum were not different
among the septic groups, independent of their thiamine
status. In addition, CLP increased the number of bacteria
in the peritoneum, except in the TD group, where the
bacterial recovery was similar to that observed in the sham
groups.
The level of TNF-α in the peritoneal fluid of the septic
animals fed with TD chow was significantly greater than
that observed in the other groups. TNF-α is a cytokine
of the early innate inflammatory response. It is produced
within the first hour of injury, with a peak between the
second and third hours following injury. For this reason,
it is not usually used in the monitoring of septic patients
[51] because the timing of the peak TNF-α level may have
already passed when these patients are first evaluated.
However, TNF-α is an early marker of inflammationcommonly used in sepsis models [47]. TNF-α is a marker
of the activity of NK cells and macrophages and may help
explain the increased bacterial clearance in the peritoneal
fluid that was observed in the CLP mice fed the TD chow
used in this study. In addition, we observed a persistent
high level of TNF-α in the peritoneal fluid of the CLP
mice fed the TD chow, although the number of total leu-
kocytes, monocytes and neutrophils in the peritoneal fluid
was similar between the septic animals, independent of
their thiamine status. This finding suggests that TD may
not change cellular recruitment into the peritoneal cavity
following sepsis and that another mechanism may be
involved in the increased peritoneal bacterial killing
observed in the CLP group fed with TD chow, possibly
mediated by TNF-α.
Lipid peroxidation is one of the hallmarks of the oxi-
dative stress. Lipid peroxides are usually decomposed
into reactive aldehydes such as malondialdehyde (MDA)
and 4-hydroxy-2-nonenal (4-HNE), which are also react-
ive oxygen species. Due to its electrophilic properties,
the aldehyde 4-HNE forms adducts with cellular pro-
teins [52]. The present study also demonstrated a greater
level of liver proteins modified by 4-HNE in the animals
subjected to TD chow compared with what was ob-
served in the other groups. This finding was expected,
considering that thiamine may be associated with a
lower efficiency of cellular reducing power, since enzymes
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responsible for increasing NADH levels in the cell,
favoring oxidative stress. Thus, one could suppose that
thiamine deficiency also creates greater oxidative stress
in the peritoneal cavity, therefore potentially inhibiting
bacterial proliferation. The increased bacterial clearance
that was observed in this study might initially suggest a
better outcome against sepsis in these animals; however,
the increased inflammation, as was observed with the
increased TNF-α levels, may also be detrimental to
sepsis outcomes. Indeed, it was reported that following
CLP, an increased mortality rate occurred in animals
that displayed an unbalanced inflammatory response,
despite a greater bacterial clearance [53].
Extending the analysis of inflammation beyond the first
24 hours after the initiation of sepsis may present a more
complete picture of the dynamics of the interleukins.
It is important to remember that the model of sepsis
used in the present study can be adjusted to induce a
low mortality rate, which may also allow for the investi-
gation of thiamine deficiency in the mechanisms of
immunologic tolerance.
Conclusions
TD was associated with a greater bacterial clearance in the
peritoneal fluid, greater oxidative stress and a change in
the immune response profile in an experimental model of
abdominal sepsis in mice. Further investigation is needed
to define the impact of these changes on the severity of
sepsis, septic mortality, and also to elucidate the participa-
tion of other cellular and biochemical mechanisms.
Abbreviations
4-HNE: 4-hydroxy 2-nonenal; AIN93G: Kind of animal feed suggested by the
American Institute of Nutrition in 1993; CFU: Colony-forming unit; CLP: Cecal
ligation and puncture; GSH: Glutathione; HPLC: High performance liquid
chromatography; IL-10: Interleukin-10; IL-1beta: Interleukin 1 beta; IL-
6: Interleukin 6; iNOS: Inducible form of nitric oxide synthase;
KC: Keratinocyte chemoattractant; MCP-1/CCL2: Monocyte chemotactic
protein-1; NADPH: Nicotinamide adenine dinucleotide phosphate;
NK: Natural killer cells; nmol/L: Nanomole per liter; ROS: Reactive oxygen
species; SIRS: Systemic inflammatory response syndrome; TCA: Trichloroacetic
acid; TD: Thiamine deficiency; TNF-alpha: Tumor necrosis factor alpha;
TPP: Thiamine pyrophosphate; alpha-KGDH: Alpha-ketoglutarate
dehydrogenase.
Competing interests
The authors declare that they have no competing interest.
Authors’ contributions
Conceived and designed the experiments: JAAA, VLFCB, JCBN, PTB and SC.
Performed the experiments: JAAA, CRMG, NPAN, SCAJ, MGATC, RMC, and
RNG. Analyzed the data: JAAA, MCP, VLFCB, JCBN, MBAML, CRMG, NPAN,
SCAJ, MGATC, RM, RNG, PTB and SC. Contributed reagents/materials/analysis
tools: MCP, VLFCB, JCBN, RNG, PTB and CAML. Wrote the paper: JAAA, CAML,
PTB, and SC. All the authors have read and approved the final manuscript.
Acknowledgements
The study was supported by PROAP/CAPES. We thank Lin Machado de Lima,
Roosevelt Aguiar Dias and Paulo Roberto Marques for their skillful assistance.Author details
1Intensive Care Unit, Pedro Ernesto University Hospital, State University of Rio
de Janeiro, Av. 28 de Setembro 87, Rio de Janeiro, RJ CEP 20551-030, Brazil.
2Biochemistry Department, Biomedical Center, Institute of Biology, State
University of Rio de Janeiro, Rio de Janeiro, Brazil. 3Immunopharmacology
Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil. 4Morphometry,
Metabolism & Cardiovascular Laboratory; Biomedical Center, Institute of
Biology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Received: 21 July 2013 Accepted: 14 April 2014
Published: 24 April 2014
References
1. American College of Chest Physicians/Society of Critical Care Medicine:
Consensus conference. Definitions for sepsis and organ failure and
guidelines for the use of innovative therapies in sepsis. Crit Care Med
1992, 20:864–874.
2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E,
Tomlanovich M: Early goal-directed therapy in the treatment of severe
sepsis and septic shock. N Engl J Med 2001, 345:1368–1377.
3. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K,
Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H,
Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson
BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving sepsis
campaign: international guidelines for management of severe sepsis and
septic shock. Crit Care Med 2008, 36(1):296–327.
4. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S,
Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D,
Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H,
Hartog C, Loeffler M, Reinhart K: Epidemiology of sepsis in Germany:
results from a national prospective multicenter study. Intensive Care Med
2007, 33(4):606–618.
5. Záhorec R, Firment J, Straková J, Mikula J, Malík P, Novák I, Zeman J, Chlebo
P: Epidemiology of severe sepsis in intensive care units in the Slovak
Republic. Infection 2005, 33(3):122–128.
6. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR:
Epidemiology of severe sepsis in the United States: analysis of incidence,
outcome, and associated costs of care. Crit Care Med 2001, 29:1303–1310.
7. Sales Júnior JAL, David CM, Hatum R, Souza PCSP, Japiassú AM, Cleovaldo
TS, Pinheiro CTS, Friedman G, Silva OB, Dias MDA, Koterba E, Dias FS, Piras C,
Luiz RR: Sepse Brasil: epidemiological study of sepsis in intensive care
units brazilian. Braz J Intensive Care 2006, 18(1):9–17.
8. Silva E, Pedro MA, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, Cal RG,
de Sousa EF, Abe TP, de Andrade J, de Matos JD, Rezende E, Assunção M,
Avezum A, Rocha PC, de Matos GF, Bento AM, Corrêa AD, Vieira PC, Knobel
E: Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 2004,
8(4):251–260.
9. Soriano FG: Sepsis: Celular, Tissue and Organ Alterations In Experimental
Model Of Sepsis. Role of Cytokines and Gene Expression. In PhD Thesis.
São Paulo University: Medicine School; 2006.
10. Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D,
Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa
A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H: Cardiovascular,
infections, pneumonia and sepsis, critical care organization and
outcome, education, ultrasonography, metabolism and coagulation.
Intensive Care Med 2012, 38(3):345–358.
11. Sogayar AMC, Machado FR, Rea-Neto A, Dornas A, Grion CMC, Lobo SMA:
Prospective study to evaluate costs of septic patients in brazilian
intensive care units. Pharmacoecon 2008, 26(5):425–434.
12. Butterworth RF: Thiamine. In Modern Nutrition in Health and Disease. 10th
edition. Edited by Shils ME. Lippincott: Williams & Wilkins; 2006:426–433.
13. Mclain AL, Szweda PA, Szweda LI: α-Ketoglutarate dehydrogenase: a
mitochondrial redox sensor. Free Radic Res 2011, 45(1):29–36.
14. Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP,
Ngo L: Thiamine deficiency in critically ill patients with sepsis. J Crit Care
2010, 25:576–581.
15. Manzanares W, Hardy G: Thiamine supplementation in the critically ill.
Curr Opin Clin Nutr Metab Care 2011, 14(6):610–617.
16. Lima LFP, Leite HP, Taddei JAAC: Low blood thiamine concentrations in
children upon admission to the intensive care unit: risk factors and
prognostic significance. Am J Clin Nutr 2011, 93(1):57–61.
de Andrade et al. Journal of Inflammation 2014, 11:11 Page 10 of 10
http://www.journal-inflammation.com/content/11/1/1117. Schoenenberger AW, Schoenenberger-Berzins R, Maur C, Suter M, Vergopoulos
A, Erne M: Thiamine supplementation in symptomatic chronic heart failure:
a randomized, double-blind, placebo-controlled, cross-over pilot study.
Clin Res Cardiol 2012, 101:159–164.
18. Sriram K, Manzanares W, Joseph K: Thiamine in nutrition therapy. Nutr Clin
Pract 2012, 27(1):41–50.
19. Azizi-Namini P, Ahmed M, Yan AT, Keith M: The role of B vitamins in the
management of heart failure. Nutr Clin Pract 2012, 27(3):363–374.
20. Cunha S, Cunha JB, Salles JB, Silva MC, Cunha Bastos VL, Mandarim-
De-Lacerda CA: Cardiac alterations in furosemide-treated thiamine-
deprived rats. J Card Fail 2007, 13(9):774–784.
21. Gioda CR, Barreto TO, Prímola-Gomes TN, De Lima DC, Campos PP, Capettini
LS, Lauton-Santos S, Vasconcelos AC, Coimbra CC, Lemos VS, Pesquero JL, Cruz
JS: Cardiac oxidative stress is involved in heart failure induced by thiamine
deprivation in rats. Am J Physiol Heart Circ Physiol 2010, 298:2039–2045.
22. Wang Y, Cheng J, Chen G, Rob F, Naseem RH, Ngyen L, Johnstone JL, Hill
JA: Remodeling of outward K+ currents in pressure-overload heart
failure. J Cardiovasc Electrophysiol 2007, 18(2):869–875.
23. Wang JJL, Hua Z, Fentress HM, Singleton CK: JNK1 is inactivated during
thiamine deficiency-induced apoptosis in human neuroblastoma cells.
J Nutr Biochem 2000, 11:208–215.
24. Hazell AS: Astrocytes are a major target in thiamine deficiency and
Wernicke’s encephalopathy. Neurochem Int 2009, 55(1):129–135.
25. Hazell AS, Butterworth RF: Update of cell damage mechanisms in
thiamine deficiency: focus on oxidative stress, excitotoxicity and
inflammation. Alcohol Alcohol 2007, 44(2):141–147.
26. Hirsch JA, Parrott J: New considerations on the neuromodulatory role of
thiamine. Pharmacology 2012, 89(1–2):111–116.
27. Karuppagounder SS, Xu H, Shi Q, Chen LH, Pedrini S, Pechman D, Baker H,
Beal MF, Gandy SE, Gibson GE: Thiamine deficiency induces oxidative
stress and exacerbates the plaque pathology in Alzheimer’s mouse
model. Neurobiol Aging 2009, 30(10):1587–1600.
28. Wang X, Wang B, Fan Z, Shi X, Ke ZJ, Luo J: Thiamine deficiency induces
endoplasmic reticulum stress in neurons. Neuroscience 2007, 144:1045–1056.
29. Lindenbaum GA, Larrieu AJ, CarrolL SF, Kapusnick RA: Effect of
cocarboxylase in dogs subjected to experimental septic shock. Crit Care
Med 1989, 17(10):1036–1040.
30. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT,
Castro-Faria-Neto HC, Bozza PT: Cytokine profiles as markers of disease
severity in sepsis: a multiplex analysis. Crit Care 2007, 11(2):49.
31. Delves RPJ, Roitt D: The immune system - first of two parts. N Engl J Med
2000, 343:37–50.
32. Janeway CA, Medzhitov R: Innate immunity recognition. Annu Rev
Immunol 2002, 20:197–216.
33. Cerwenka A, Lanier LL: Natural killer cells, viruses and cancer. Nat Rev
Immunol 2001, 1:41–49.
34. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage
activation. Nat Rev Immunol 2008, 8:958–969.
35. Andriantsitohaina R, Duluc L, García-Rodríguez JC, GIL-Del Valle L, Guevara-
Garcia M, Simard G, Soleti R, Su DF, Velásquez-Pérez L, Wilson JX, Laher I:
Systems biology of antioxidants. Clin Sci 2012, 123(3):173–192.
36. Andrades ME, Arian Morina A, Spasić S, Spasojević I: Bench-to-bedside
review: sepsis - from the redox point of view. Crit Care 2011, 15(5):230.
37. Raza H, John A: 4-Hydroxynonenal induces mitochondrial oxidative stress,
apoptosis and expression of glutathione S -transferase A4-4 and cytochrome
P450 2E1 in PC12 cells. Toxicol Appl Pharmacol 2006, 216(2):309–318.
38. Zhang Y, Sano M, Shinmolura K, Tamaki K, Katsumata Y, Matsuhashi T, Morizane
S, Ito H, Hishiki T, Endo J, Zhou H, Yuasa S, Kaneda R, Suematsu M, Fukuda K: 4-
Hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via
the Nrf2-dependent pathway. J Mol Cell Cardiol 2010, 49:576–586.
39. Sano M: Cardioprotection by hormetic responses to aldehyde. Circ J 2010,
74:1787–1793.
40. Wicherman KA, Baue AE, Chaudry IH: Sepsis and septic shock - a review of
laboratory models and a proposal. J Surg Res 1980, 29:189–201.
41. Remick DG, Peter AW: Evaluation of endotoxin models for the study of
sepsis. Shock 2005, 24(1):7–11.
42. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Loring W, Rue I,
Chaudry IH: Cecal ligation and puncture. Shock 2005, 24(1):52–57.
43. Esmon CT: Why do animal models (sometimes) fail to mimic human
sepsis? Crit Care Med 2004, 32:219–222.44. Rittirsch D, Hoesel LM, Ward A: The disconnect between animal models of
sepsis and human sepsis. J Leukoc Biol 2007, 81:137–143.
45. Machado CJS, Filipecki ATP, Teixeira MO: Current Brazilian law on animal
experimentation. Science 2009, 324(5935):1643–1644.
46. Reeves PG, Nielsen FH, Fahey JRGC: AIN-93 purified diets for laboratory
rodents: final report of the american institute of nutrition ad hoc writing
committee on the reformulation of the ain-76a rodent diet. J Nutr 1993,
123:1939–1951.
47. Gomes RN: Therapeutical Potential Of The Paf Acetilhidrolase (Paf-Ah) In
The Control Of Sepsis. In Thesis. Rio de Janeiro: Oswaldo Cruz Institute; 2006.
48. Lu J, Frank EL: Rapid HPLC measurement of thiamine and its phosphate
esters in whole blood. Clin Chem 2008, 54(5):901–906.
49. Kurisaki E, Hiraiwa K: Western blot analysis for 4-hydroxy-2-nonenal
(HNE)-modified proteins in paraquat-treated mice. Legal Med 2009,
11:431–433.
50. Zar J: Biostatistical analysis. 4th edition. Prentice Hall: Upper Saddle River; 1999.
51. Bozza FA, Bozza PT, Faria-Neto HC: Beyond sepsis pathophysiology with
cytokines: what is their value as biomarkers for disease severity? Mem
Inst Oswaldo Cruz 2005, 100:217–221.
52. Catalá A: Lipid peroxidation of membrane phospholipids generates
hydroxy-alkenals and oxidized phospholipids active in physiological
and/or pathological conditions. Chem Phys Lipids 2009, 157:1–11.
53. Gomes RN, Teixeira-Cunha MG, Figueiredo RT, Almeida PE, Alves SC, Bozza PT,
Bozza FA, Bozza MT, Zimmerman GA, Castro-Faria-Neto HC: Bacterial clearance
in septic mice is modulated by MCP-1/CCL2 and nitric oxide. Shock 2013,
39(1):63–69.
doi:10.1186/1476-9255-11-11
Cite this article as: de Andrade et al.: The effect of thiamine deficiency
on inflammation, oxidative stress and cellular migration in an
experimental model of sepsis. Journal of Inflammation 2014 11:11.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
